1. Home
  2. EQH vs PRAX Comparison

EQH vs PRAX Comparison

Compare EQH & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equitable Holdings Inc.

EQH

Equitable Holdings Inc.

N/A

Current Price

$38.18

Market Cap

11.4B

Sector

Finance

ML Signal

N/A

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

N/A

Current Price

$295.77

Market Cap

9.6B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EQH
PRAX
Founded
1859
2015
Country
United States
United States
Employees
8000
N/A
Industry
Specialty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.4B
9.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
EQH
PRAX
Price
$38.18
$295.77
Analyst Decision
Buy
Strong Buy
Analyst Count
10
15
Target Price
$60.80
$572.13
AVG Volume (30 Days)
2.8M
331.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
2.75%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$43.41
N/A
Revenue Next Year
$7.61
$6,395.88
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$37.51
$26.70
52 Week High
$56.61
$354.87

Technical Indicators

Market Signals
Indicator
EQH
PRAX
Relative Strength Index (RSI) 30.88 36.94
Support Level N/A $290.36
Resistance Level $55.05 $322.32
Average True Range (ATR) 1.69 18.62
MACD -0.28 -5.97
Stochastic Oscillator 7.65 2.53

Price Performance

Historical Comparison
EQH
PRAX

About EQH Equitable Holdings Inc.

Equitable Holdings Inc is a financial services company providing retirement, asset management, and wealth management solutions for individual and institutional clients, operating through three segments. The Retirement segment generates the majority of revenue and offers annuities, retirement savings plans, institutional savings products, and includes the spread lending business. The Asset Management segment provides diversified investment management and related services globally through Institutional, Retail, and Private Wealth channels and reflects the business of AB. The Wealth Management segment offers advisory accounts, financial planning and advice, life insurance, and annuity products. Revenues are earned predominantly from fee income, income from investments, and insurance premiums.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: